HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew M Tershakovec Selected Research

Simvastatin (Zocor)

10/2021Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT.
9/2020Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-IT.
12/2017Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
7/2017Real-world data to assess changes in low-density lipoprotein cholesterol and predicted cardiovascular risk after ezetimibe discontinuation post reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial.
1/2017Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial.
12/2016On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT).
2/2016Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.
1/2016Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?
1/2016Statin combination therapy and cardiovascular risk reduction.
1/2016Inverse relationship between high-density lipoprotein cholesterol raising and high-sensitivity C-reactive protein reduction in older patients treated with lipid-lowering therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew M Tershakovec Research Topics

Disease

24Coronary Disease (Coronary Heart Disease)
01/2019 - 11/2005
16Hypercholesterolemia
01/2019 - 12/2006
14Cardiovascular Diseases (Cardiovascular Disease)
11/2019 - 11/2005
11Acute Coronary Syndrome
10/2021 - 08/2014
11Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2016 - 10/2005
10Vascular Diseases (Vascular Disease)
05/2014 - 12/2009
9Type 2 Diabetes Mellitus (MODY)
05/2015 - 11/2005
7Stroke (Strokes)
12/2017 - 11/2005
7Pain (Aches)
03/2008 - 02/2006
6Hyperlipidemias (Hyperlipidemia)
08/2013 - 04/2008
5Myocardial Infarction
01/2017 - 12/2010
5Insulin Resistance
12/2016 - 11/2005
5Diabetes Mellitus
12/2016 - 02/2009
5Dyslipidemias (Dyslipidemia)
10/2015 - 02/2008
3Atherosclerosis
01/2019 - 03/2012
3Unstable Angina
02/2016 - 08/2014
3Flushing
08/2012 - 04/2008
3Hepatitis
08/2011 - 12/2006
3Obesity
05/2010 - 10/2005
3Osteoarthritis
09/2009 - 02/2006
2Neoplasms (Cancer)
09/2020 - 01/2017
2Ischemic Stroke
12/2017 - 11/2014
2Hemorrhagic Stroke
12/2017 - 01/2017
2Abdominal Obesity
09/2015 - 07/2013
2Hypertriglyceridemia
07/2011 - 08/2009
2Inflammation (Inflammations)
09/2009 - 02/2009
2Exanthema (Rash)
06/2009 - 12/2006
2Hypersensitivity (Allergy)
06/2009 - 12/2006
2Weight Loss (Weight Reduction)
01/2009 - 04/2003
2Hypertension (High Blood Pressure)
01/2009 - 11/2005
2Proteinuria
03/2008 - 10/2006
2Postoperative Pain
01/2007 - 07/2006
2Body Weight (Weight, Body)
10/2005 - 05/2004
1Aortic Valve Stenosis (Aortic Stenosis)
09/2020
1Chronic Cough
01/2019
1Cough
01/2019
1Dysgeusia (Parageusia)
01/2019
1Heart Failure
01/2017
1Overweight
01/2017
1Prediabetic State (Prediabetes)
12/2016
1Non-ST Elevated Myocardial Infarction
08/2014
1ST Elevation Myocardial Infarction
08/2014
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
04/2014
1Muscular Diseases (Myopathy)
12/2010
1Coronary Artery Disease (Coronary Atherosclerosis)
02/2009
1Low Back Pain (Lumbago)
03/2008

Drug/Important Bio-Agent (IBA)

41Ezetimibe (Zetia)FDA Link
10/2021 - 09/2006
32Simvastatin (Zocor)FDA LinkGeneric
10/2021 - 10/2006
30LipidsIBA
01/2019 - 05/2004
29oxidized low density lipoproteinIBA
10/2021 - 09/2006
28LDL CholesterolIBA
01/2019 - 09/2006
20Atorvastatin (Lipitor)FDA Link
01/2016 - 12/2006
19Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2021 - 09/2006
12HDL CholesterolIBA
12/2016 - 02/2008
11ApolipoproteinsIBA
09/2015 - 02/2008
10Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link
10/2021 - 02/2010
9CholesterolIBA
01/2019 - 10/2005
9C-Reactive ProteinIBA
01/2016 - 02/2008
9Lipoproteins (Lipoprotein)IBA
10/2015 - 02/2008
7LDL Lipoproteins (beta Lipoproteins)IBA
08/2013 - 12/2008
6Triglycerides (Triacylglycerol)IBA
12/2016 - 04/2008
6Rosuvastatin Calcium (Crestor)FDA Link
10/2015 - 10/2006
5Glucose (Dextrose)FDA LinkGeneric
12/2016 - 02/2010
5HDL LipoproteinsIBA
10/2015 - 08/2009
5rofecoxib (Vioxx)FDA Link
08/2007 - 02/2006
4Pharmaceutical PreparationsIBA
09/2020 - 12/2006
4Niacin (Nicotinic Acid)FDA LinkGeneric
11/2014 - 04/2008
4Apolipoproteins B (ApoB)IBA
01/2014 - 02/2008
3Adenosine Triphosphate (ATP)IBA
01/2019 - 09/2006
3Apolipoprotein A-I (Apolipoprotein A1)IBA
07/2013 - 12/2008
3EtoricoxibIBA
09/2009 - 07/2007
2Biomarkers (Surrogate Marker)IBA
07/2017 - 10/2015
2Fenofibrate (CiL)FDA LinkGeneric
07/2011 - 08/2009
2Celecoxib (Celebrex)FDA Link
09/2009 - 07/2006
2Antihypertensive Agents (Antihypertensives)IBA
03/2008 - 11/2005
1lipoprotein cholesterolIBA
11/2019
1GefapixantIBA
01/2019
11-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
10/2015
1antineoplaston A10 (A 10)IBA
10/2015
1Glycated Serum AlbuminIBA
05/2015
1Fibric Acids (Fibrates)IBA
11/2014
1Bile Acids and Salts (Bile Acids)IBA
11/2014
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
05/2014
1VLDL CholesterolIBA
07/2013
1IDL Lipoproteins (Lipoprotein, IDL)IBA
08/2012
1MK-0524IBA
08/2012
1Anticholesteremic AgentsIBA
12/2010
1Hypolipidemic Agents (Antihyperlipidemics)IBA
12/2010
1S 10 (S-10)IBA
12/2009
1Protein Kinases (Protein Kinase)IBA
09/2009
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
09/2009
1Indicators and Reagents (Reagents)IBA
08/2009
1Insulin (Novolin)FDA Link
01/2009
1remnant-like particle cholesterolIBA
04/2008

Therapy/Procedure

32Therapeutics
01/2019 - 05/2004
3Secondary Prevention
01/2016 - 12/2010
2Aftercare (After-Treatment)
01/2016 - 09/2015
2Drug Therapy (Chemotherapy)
09/2015 - 11/2005
2Patient Readmission
06/2015 - 08/2014
1Cholecystectomy
02/2010